Navigation Links
A new chemotherapeutic target for hepatocellular carcinoma
Date:10/25/2007

Hepatocellular carcinoma (HCC) is a major health problem worldwide. Currently, the only chance for obtaining a cure in patients with HCC is by either a surgical resection or liver transplantation. However, many HCCs with scattered tumors cannot be operated on. In such patients, effective alternative therapies need to be discovered in order to treat patients in the early stages of this disease.

An article to be published on 28 October in the World Journal of Gastroenterology proposes a new target for therapy. A study was conducted by Dr. Satoshi Mamori, of Jikei University, in which he evaluated tumor biopsies in order to confirm the diagnosis of HCC.

The immunohistochemical expression of survivin in liver tumor specimens obtained from 17 patients was studied. In addition, to determine the survivin expression in response to anti-cancer drugs in early stage HCC, the survivin expression was determined after treating HCC cells with anti-cancer drugs under hypoxic culture conditions.

Survivin is a member of a family of inhibitors of apoptosis protein (IAP), which has been implicated in both the control of cell division and the inhibition of apoptosis. Survivin is selectively expressed in most common human neoplasms and it also appears to be involved in tumor cell resistance to some anticancer agents and ionizing radiation. Several preclinical studies have demonstrated a down-regulation of the survivin expression/function by the use of anti-sense oligonucleotide, dominant negative mutants, ribozymes, small interfering RNAs and cyclin-dependent kinase inhibitors to increase the rate of apoptosis, while also reducing the tumor growth potential and sensitized tumor cells to various chemotherapeutic drugs and -irradiation using both in vitro and in vivo models of various types of human tumors.

The results and conclusions demonstrated survivin protein to be expressed in 64.7% of the cells in early HCC specimens (median). In early stag
'/>"/>

Contact: You-De Chang
y.d.chang@wjgnet.com
0086-108-538-1892
World Journal of Gastroenterology
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Cytokine IL6 as a New Chemotherapeutic Target for Ras-driven Cancers
2. Feeding channel created by malaria parasite - a new target for malaria treatments
3. In Search Of A New Drug To Target Cholesterol
4. Enzyme may be target for obesity drugs
5. Target for obesity treatment
6. Scios Inc. targets drug giants in arthritis war
7. Pharmaceutical companies are targeting patients
8. New target for antidiabetic agents identified
9. Gel Offers A More Targeted Approach
10. In Search Of A New Drug To Target Cholesterol
11. Target of diabetes type 1 identified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...swire-USNewswire/ -- The American Heart,Associatio... Lewis,Achievement Award, the association,s highes...ard was established in 2000, to recognize and hono...edical journalists who have documented,the conside...ease and,stroke. This career achievement award was...
(Date:7/23/2008)...23 /PRNewswire-USNewswire/ -- The Alameda County,P...ly 24-26 at the Oakland,Marriott to address the so...in individuals from low-income and communities of ...s and counties will attend. Place Matters,is a nat... and Economic,Studies, Health Policy Institute and...
(Date:7/23/2008)...e Dangerous for Morbidly Obese Women? ,As the ...are consulting plastic surgeons for breast reducti...ad been thought to have higher complication rates....e as safe to perform large-volume breast reduction...Study title: Breast Reduction: Safe in the Morbidl...
(Date:7/23/2008)...23 /PRNewswire-USNewswire/ -- The New Jersey,Hospi...t Safety has,received a planning grant for $199,50...o develop a proposal for improving the quality of,...termine over the next six months whether New,Jerse... Quality initiative,which is focused on lifting t...
Breaking Medicine News(10 mins):Health News:Alameda County Hosts National Initiative to Reduce Health Disparities 2
...ason some adolescents experience depression could ...d nearly 30 adolescents between ages 13 to 18, hal...disorder. Magnetic resonance imaging was performed...ft and right hippocampus. The results indicated th...
...and women, 60 to 96 years old, who suffered from l...sarcopenia.// The individuals trained for eight to... strength ranging from 113 percent to 174 percent....uscle loss by incorporating a weight training rout...
...u fat. In an editorial published in the Jan. 10 is...hwestern University researchers stress the need //...ty in the United States by studying how loss of sl...ys that control appetite, food intake and energy e...
...ng been associated with cancers, fibrosis and othe...searchers say // exposure to asbestos may lay the ...rheumatoid arthritis and multiple sclerosis. Resea..., which is known to be polluted by asbestos. They ...
Other Medicine News:Health News:Sleeping Less May be related to Weight Gain 2
(Date:7/23/2008)...de BioPharmaceutics, Inc.,an emerging biopharmace...esults demonstrating the utility of their lead dru...ronic blood disorder paroxysmal nocturnal,hemoglob...ed at the XXII,International Complement Workshop i...ly treatment currently available for PNH patients ...
(Date:7/23/2008)...rotein Therapeutics that Modulate Altern...ss., July 23 /- Taligen Therapeutics ...growth plan with the,appointment of Abbie Celniker...ishment of its headquarters in Cambridge, Mass. Dr...nder of the company who remains president., Under...
(Date:7/22/2008)...er 293-patient European, trial -, http://www.cr... MONTREAL, July 22 / CryoCa...therapy products to treat cardiac,arrhythmias, tod...m three,European study centers using the Company,s...lier today in the Journal of the American College ...
(Date:7/22/2008)...t Initiative bring MJFF,s,current active industry ...09, NEW YORK, July 22 /PRNewswire-USNewswire/ -- ...ormative treatments and a cure for Parkinson,s,dis...s Research has awarded,$2.7 million in total fundi... granted under MJFF,s Therapeutics Development Ini...
Breaking Medicine Technology:InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Vaginal progesterone gel may improve infant outcomes and 2659 1Vaginal progesterone gel may improve infant outcomes and 2659 2Vaginal progesterone gel may improve infant outcomes and 2659 3Vaginal progesterone gel may improve infant outcomes and 2659 4Study Supports Change to Prostate Cancer Biopsy 2657 1Study Supports Change to Prostate Cancer Biopsy 2657 2Study Supports Change to Prostate Cancer Biopsy 2657 3Angel Flight West Recognizes Colorado Pilots and Supporters at AFW 24th Anniversary Awards 2655 1Angel Flight West Recognizes Colorado Pilots and Supporters at AFW 24th Anniversary Awards 2655 2Study Determines Breast Specific Gamma Imaging Has Higher Specificity Than MRI in Patients With Equivocal Mammograms 2652 1Study Determines Breast Specific Gamma Imaging Has Higher Specificity Than MRI in Patients With Equivocal Mammograms 2652 2Study Determines Breast Specific Gamma Imaging Has Higher Specificity Than MRI in Patients With Equivocal Mammograms 2652 3
...I Pharma, Inc.,(Nasdaq:MOGN), a biopharmaceutical ...provided highlights of data presentations made,dur... (ASCO) Annual,Meeting. Dacogen (decitabine) for I... the presentation of efficacy data in older,patien...ity,observed in patients with refractory acute lym...
...2007 - Synta,Pharmaceuticals Corp., (NASDAQ: SNTA)...g, developing, and commercializing small,molecule ...nounced,it will hold a conference call at 2:30 p.m... be presented at the annual meeting of the,America...Illinois,this morning., The conference call will b...
Other Medicine Technology:MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 10
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
Medicine Products: